Dr James J Otting, MD | |
5085 Monroe St, Toledo, OH 43623 | |
(567) 408-7703 | |
(567) 408-7702 |
Full Name | Dr James J Otting |
---|---|
Gender | Male |
Speciality | Pain Management |
Experience | 18 Years |
Location | 5085 Monroe St, Toledo, Ohio |
Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1497953749 | NPI | - | NPPES |
0055369 | Medicaid | OH | |
1497953749 | Medicaid | MI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | MT191166 (Pennsylvania) | Secondary |
208VP0014X | Pain Medicine - Interventional Pain Medicine | 5315051155 (Michigan) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Promedica Monroe Regional Hospital | Monroe, MI | Hospital |
Mercy St Vincent Medical Center | Toledo, OH | Hospital |
Bay Park Community Hospital | Oregon, OH | Hospital |
Promedica Toledo Hospital | Toledo, OH | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Toledo Pain Services, Pll | 8921912189 | 14 |
Mercy Memorial Hospital Corporation | 7012811615 | 28 |
News Archive
Response Biomedical Corporation (TSX:RBM) (OTCBB:RPBIF) reported that clinical products revenue for the three and six month periods ended June 30, 2009 increased 373% and 208% to $1,805,308 and $3,548,014, respectively, compared to $381,615 and $1,150,760 for the same periods in 2008.
BioMed Realty Trust, Inc. today announced that its operating partnership subsidiary, BioMed Realty, L.P., priced a private placement of $150.0 million aggregate principal amount of 3.75% Exchangeable Senior Notes due 2030 (the "Notes").
People with a family history of alcohol use disorder release more dopamine in the brain's main reward center in response to the expectation of alcohol than people diagnosed with the disorder, or healthy people without any family history of AUD, reports a new study in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.
Harbor BioSciences, Inc. a biopharmaceutical company developing novel therapeutics for the treatment of cancer, metabolic and inflammatory diseases, today released new positive data from its ongoing Phase I/IIa clinical trial with Apoptone(HE3235) for castration resistant prostate cancer (CRPC) – also referred to as hormone resistant prostate cancer.
› Verified 7 days ago
Entity Name | Toledo Pain Services, Pll |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1356339857 PECOS PAC ID: 8921912189 Enrollment ID: O20031113000215 |
News Archive
Response Biomedical Corporation (TSX:RBM) (OTCBB:RPBIF) reported that clinical products revenue for the three and six month periods ended June 30, 2009 increased 373% and 208% to $1,805,308 and $3,548,014, respectively, compared to $381,615 and $1,150,760 for the same periods in 2008.
BioMed Realty Trust, Inc. today announced that its operating partnership subsidiary, BioMed Realty, L.P., priced a private placement of $150.0 million aggregate principal amount of 3.75% Exchangeable Senior Notes due 2030 (the "Notes").
People with a family history of alcohol use disorder release more dopamine in the brain's main reward center in response to the expectation of alcohol than people diagnosed with the disorder, or healthy people without any family history of AUD, reports a new study in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.
Harbor BioSciences, Inc. a biopharmaceutical company developing novel therapeutics for the treatment of cancer, metabolic and inflammatory diseases, today released new positive data from its ongoing Phase I/IIa clinical trial with Apoptone(HE3235) for castration resistant prostate cancer (CRPC) – also referred to as hormone resistant prostate cancer.
› Verified 7 days ago
Entity Name | Jj Otting, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1982136982 PECOS PAC ID: 7214206853 Enrollment ID: O20171128003850 |
News Archive
Response Biomedical Corporation (TSX:RBM) (OTCBB:RPBIF) reported that clinical products revenue for the three and six month periods ended June 30, 2009 increased 373% and 208% to $1,805,308 and $3,548,014, respectively, compared to $381,615 and $1,150,760 for the same periods in 2008.
BioMed Realty Trust, Inc. today announced that its operating partnership subsidiary, BioMed Realty, L.P., priced a private placement of $150.0 million aggregate principal amount of 3.75% Exchangeable Senior Notes due 2030 (the "Notes").
People with a family history of alcohol use disorder release more dopamine in the brain's main reward center in response to the expectation of alcohol than people diagnosed with the disorder, or healthy people without any family history of AUD, reports a new study in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.
Harbor BioSciences, Inc. a biopharmaceutical company developing novel therapeutics for the treatment of cancer, metabolic and inflammatory diseases, today released new positive data from its ongoing Phase I/IIa clinical trial with Apoptone(HE3235) for castration resistant prostate cancer (CRPC) – also referred to as hormone resistant prostate cancer.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr James J Otting, MD 5085 Monroe St, Toledo, OH 43623-3455 Ph: (567) 408-7703 | Dr James J Otting, MD 5085 Monroe St, Toledo, OH 43623 Ph: (567) 408-7703 |
News Archive
Response Biomedical Corporation (TSX:RBM) (OTCBB:RPBIF) reported that clinical products revenue for the three and six month periods ended June 30, 2009 increased 373% and 208% to $1,805,308 and $3,548,014, respectively, compared to $381,615 and $1,150,760 for the same periods in 2008.
BioMed Realty Trust, Inc. today announced that its operating partnership subsidiary, BioMed Realty, L.P., priced a private placement of $150.0 million aggregate principal amount of 3.75% Exchangeable Senior Notes due 2030 (the "Notes").
People with a family history of alcohol use disorder release more dopamine in the brain's main reward center in response to the expectation of alcohol than people diagnosed with the disorder, or healthy people without any family history of AUD, reports a new study in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.
Harbor BioSciences, Inc. a biopharmaceutical company developing novel therapeutics for the treatment of cancer, metabolic and inflammatory diseases, today released new positive data from its ongoing Phase I/IIa clinical trial with Apoptone(HE3235) for castration resistant prostate cancer (CRPC) – also referred to as hormone resistant prostate cancer.
› Verified 7 days ago
Nadeem Nawaz Moghal, MD Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 3400 Meijer Dr, Toledo, OH 43617 Phone: 419-843-1370 Fax: 419-843-1362 | |
Dr. Amar Nath Goyal, M.D. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 3900 Sunforest Court, Suite 132, Toledo, OH 43623 Phone: 419-490-7131 Fax: 330-230-2865 | |
Dr. Ashok R Salvi, MD Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 4235 Secor Rd, Toledo, OH 43623 Phone: 419-479-5418 | |
Amanda Jo Mcdole, Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 3400 Meijer Dr, Toledo, OH 43617 Phone: 419-843-1370 | |
William George James Jr., MD Pain Medicine Medicare: May Accept Medicare Assignments Practice Location: 3400 Meijer Dr, Toledo, OH 43617 Phone: 419-843-1370 Fax: 419-843-1362 | |
James C Chang, M.D. Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 7053 W Central Ave, Toledo, OH 43617 Phone: 419-843-1370 Fax: 419-843-8402 |